Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Endomagnetics Raises Additional Funding and Opens Cambridge Office

Abstract:
Endomagnetics, the company which is using advanced magnetic technology to extend the availability of an important cancer staging procedure, has raised additional funding, taking the sum raised in the last few months to £1.8 million. The Company has also announced a move to Cambridge as it expands its operations.

Endomagnetics Raises Additional Funding and Opens Cambridge Office

Cambridge, UK | Posted on November 11th, 2011

Endomagnetics is a spin out from University College London (UCL), and is developing advanced magnetic sensors originally developed at UCL and at the University of Houston. The move to Cambridge reflects the company's rapid progress towards commercialisation of its first product. SentiMag® is an ultrasensitive hand-held probe capable of tracking the position of an associated magnetic tracer: Sienna+™, that helps to identify critical lymph nodes in support of cancer staging.

The system is now becoming available to clinicians to replace the radioactive isotopes currently used. Not only is the Endomagnetics system simpler and cheaper than the ‘gamma probe' technique currently used, but it provides a better experience for patients, surgeons and hospitals alike.

The additional investment has been provided by New Wave Ventures alongside internal investors, as an extension to the recent funding round that raised £1.2m in August.

"We are excited about the progress which Endomagnetics is making in the development of this important technique, and in the potential for its adoption around the world", said Tim Bullock, Chief Executive of New Wave Ventures. "Presently, only a small minority of people have access to the best standard of care techniques which magnetic sensing facilitates."

Speaking from the company's new headquarters on Cambridge Science Park, Endomagnetics CEO Dr Eric Mayes agreed: "We are delighted to be expanding our operations to Cambridge, close to so many other excellent technology companies and management talent. We expect to make full use of this as we expand."

Next month, Endomagnetics will be demonstrating SentiMag to surgeons and oncologists at the Breast Cancer Symposium in San Antonio, Texas, and anticipates another enthusiastic reception from clinicians attending.

####

About Endomagnetics
Endomagnetics was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.



The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for detecting a magnetic tracer called Sienna+™ to help identify critical lymph nodes in support of cancer staging. Cambridge-based Endomagnetics is in the process of delivering its technology to global markets. For more information please visit www.endomagnetics.com.

About New Wave Ventures

New Wave Ventures LLP was formed as a vehicle for the personal business investments of its founders, Paul Newey and Tim Bullock. New Wave has no external investors or investment committee and addresses each investment opportunity with an open mind - aiming to achieve the most satisfactory structure for all parties. New Wave’s preference is to invest in high quality management teams with a strongly differentiated product and the potential to make a significant impact on markets with global scale.

For more information please visit www.nwventures.co.uk

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695


Company contact:
Dr Eric Mayes
CEO
Endomagnetics Ltd
Tel: +44 (0)1223 437131

Copyright © Endomagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 5, 2019 January 18th, 2019

ULVAC Inc., and Oxford Instruments Plasma Technology collaborate to bring Atomic Scale Processing solutions to the Japanese Power and RF markets January 18th, 2019

Kiel physicists discover new effect in the interaction of plasmas with solids January 18th, 2019

Brilliant glow of paint-on semiconductors comes from ornate quantum physics January 18th, 2019

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp.’s Portfolio Company, TheStreet, Inc., Agrees to Sell Its Institutional Business Units to Euromoney Institutional Investor PLC for $87.3 Million December 6th, 2018

180 Degree Capital Corp. Reports Net Asset Value Per Share of $2.81 as of September 30, 2018; a Decrease of 3.4% From June 30, 2018 October 29th, 2018

180 Degree Capital Corp. to Report Third Quarter 2018 Financial Results on Monday, October 29, 2018 and to Host a Conference Call on Tuesday, October 30, 2018 October 24th, 2018

Openings/New facilities/Groundbreaking/Expansion

Mirrorcle laser-cuts ribbon on cleanroom facility for volume MEMS mirror production November 26th, 2018

Park Systems Announces Grand Opening Ceremony for Their New Office in Beijing China November 19th, 2018

Nanomedicine

Nanobiotix Plans to Conduct Registered Public Offering in the United States January 17th, 2019

Chirality in 'real-time' January 14th, 2019

Ultra-sensitive sensor with gold nanoparticle array January 9th, 2019

Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-ANG3 for Treatment of Dyslipidemias and Metabolic Diseases January 7th, 2019

Sensors

Ultra-sensitive sensor with gold nanoparticle array January 9th, 2019

Study on low noise, high-performance transistors may bring innovations in electronics December 28th, 2018

Emerging trends in advanced nano-materials based electrochemical geno-sensors December 28th, 2018

Oxford Instruments participates in the launch of the European Quantum Technology Flagship Programme ‘QMiCS’ December 13th, 2018

Announcements

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 5, 2019 January 18th, 2019

ULVAC Inc., and Oxford Instruments Plasma Technology collaborate to bring Atomic Scale Processing solutions to the Japanese Power and RF markets January 18th, 2019

Kiel physicists discover new effect in the interaction of plasmas with solids January 18th, 2019

Brilliant glow of paint-on semiconductors comes from ornate quantum physics January 18th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project